DRC Pilot and Feasibility Grant Program Overview
The University of Pennsylvania Diabetes Research Center (DRC) is pleased to have awarded the 2013 pilot and feasibility grants in diabetes and related endocrine and metabolic disorders, and thus is no longer accepting applications in FY13. Please check again for information about the deadline for the 2014 DRC Pilot and Feasibility Awards.
The P&F program is particularly directed at new investigators and established investigators new to diabetes research. Established diabetes investigators pursuing high impact/high risk projects or projects that are a significant departure from their usual work are also eligible for support under the DRC P&F program. Applications are welcome from basic, clinical and translational investigators.
If human subjects will be participating in the proposed research, it will be necessary to submit an IRB approval letter. If animal research is being proposed, a copy of the IACUC approval letter is required. Approval may be pending at the time of application but funds will not be disbursed without these approval letters. Equipment, travel funds, and investigator salary are not permitted on this award.
Investigators who are currently in the first year of support through this P&F Program may reapply for an additional year of funding. Such continuation requests need to be carefully justified, however, and will be considered as a competing renewal application.
- All eligible investigators must have faculty appointments (at the commencement of the award) and be independent investigators.
- As the definition of faculty appointment varies, one is eligible for a P&F grant if they are eligible to submit an R01 as a PI at the start of the grant period.
- Applications are welcomed from basic, clinical and translational investigators.
- A second P&F grant on a separate topic is allowed for previous awardees (but only once and typically only for young investigators who demonstrated success as a result of their first P&F)
- A second year of funding is possible with demonstrated productivity. Support for a second year is not allowed if the applicant received external funding for the same project.
- Applicants must be US. citizens or have permanent visas.
Submission - Applications can now be submitted electronically. However, we are no longer accepting applications for the 2013 - 2014 award period.
Your application will include the following:
- Cover page – includes abstract/project summary of up to 250 words
- NIH-formatted biosketch for PI and collaborators
- Budget and Budget Justification: – for one year, up to $50,000; 1 page only (equipment, travel, and PI salary are not permitted on budget)
- Grant body including specific aims, research strategy (significance, innovation, approach) and preliminary studies – up to 3 pages total
- References – 1 page only
- Status of Institutional Review Board (IRB) approval for clinical studies or IACUC approval for animal use. If approvals are pending at the time of submission, they must be obtained before funding commences.
- If human subjects will be participating in the proposed research, an NIH Targeted / Planned Enrollment Table needs to be completed
- For Year 2 funding only: a progress report must be submitted and please include an NIH Inclusion Enrollment Report if human subjects were involved in your research.
- Submission is now electronic.
Grants will be reviewed by the DRC Pilot and Feasibility Review Committee and internal and external reviewers.
Funding level maximum is $50,000.
Current Award period: April 1, 2013 - March 31, 2014.
Once a grant is awarded, the responsibilities of successful applicants include involvement in the local diabetes community through seminar presentations and participation in local events of the diabetes research community, acknowledgement of Diabetes Center support in any publications emanating from the supported project, as well as progress reports and reporting of successful and independent grant applications resulting from the work supported by the DRC P&F grant.
- Awardees are required to inform the DRC in the event that the Pilot/Feasibility Project receives external funding during the project period.
- All awardees are asked to acknowledge the DRC support in all scientific posters, presentations and publications. Specific language is provided on the DRC website.
- Awardees may be invited to present a seminar at the weekly IDOM/DRC Seminar Series.
- All awardees must present a poster at the Annual Diabetes Spring Symposium in March
- A final progress report is due one month after the close of the project period. The one page report will contain a synopsis of scientific progress, a list of resulting collaborations, publications, and grants, and a description of the relationship of the project to Core usage.
- Awardees must report yearly for 5 years and every five years after on publications, grants, awards, patents and promotions on core utilization.
For additional information, please contact:
Tel: 215-898-4365, Fax: 215-898-5408
Dr. Doris Stoffers, Director
Pilot and Feasibility Grants Program
Tel: 215-573-5413, Fax: 215-898-5408